How does Neuralink's 'The Link' implant work and what are its reported issues?

Neuralink's 'The Link' implant uses 1,024 electrodes that penetrate brain tissue, controlled by a surgical robot. However, a key issue arose when 85% of electrodes retracted from the first human patient's brain, though a software update reportedly fixed most problems.

What's the main difference between Neuralink and Precision Neuroscience?

Neuralink's approach involves implanting electrodes *into* brain tissue, while Precision Neuroscience's 'Layer 7' device is a thin, flexible film that sits *on* the brain's surface, avoiding tissue damage and allowing for removal.

How does Synchron's BCI technology differ from others?

Synchron's BCI device, 'Centrode,' is the least invasive, delivered through blood vessels via a catheter and unfolding like a stent. It doesn't require brain surgery or skull incision, though it captures less detailed neural information than direct contact methods.

What breakthrough has Blackrock Neurotech achieved with their 'Move Again' system?

Blackrock Neurotech's 'Move Again' system, combined with AI, has enabled a paralyzed man with ALS to speak again using his own voice. The BCI decodes his speech intent in milliseconds, achieving an impressive 99.6% word accuracy.

What are the potential ethical concerns with BCIs?

Ethical concerns include the potential for societal division between enhanced and unenhanced humans, the murky line between medical treatment and enhancement, and future legal questions regarding brain data ownership, security, and potential hacking for nefarious purposes.

How is data security and privacy handled with BCIs?

According to Precision Neuroscience's CEO, data security and privacy are significant considerations built into the FDA's regulatory regime. Companies must operate within strict guidelines, with the FDA being very prescriptive on these issues, and companies adhering to HIPAA regulations.

The Race to Control Our Brains is Heating Up

ColdFusion

Science & Technology3 min read24 min video

Jul 21, 2025|380,804 views|13,662|1,737

Coldfusion TV Dagogo Altraide Technology Apple Google Samsung Facebook Tesla

Save to Pod

Key Moments

TL;DR

Brain-computer interfaces are advancing rapidly, with companies like Neuralink, Precision Neuroscience, and Synchron pushing the boundaries of human-machine interaction.

Key Insights

Brain-computer interfaces (BCIs) are evolving from bulky, external devices to sophisticated implants and minimally invasive technologies.

Neuralink, founded by Elon Musk, aims for ambitious goals including human-AI symbiosis, but faces challenges like electrode retraction and FDA scrutiny.

Precision Neuroscience, co-founded by a former Neuralink member, focuses on less invasive, physician-led approaches prioritizing patient care and safety over enhancement.

Synchron offers a unique approach by delivering BCIs via blood vessels, eliminating the need for brain surgery but with potentially lower signal resolution.

Blackrock Neurotech's 'Move Again' system has achieved remarkable success in restoring speech for an ALS patient with high accuracy.

The rapid advancement of BCIs raises significant ethical and legal questions regarding human identity, data ownership, privacy, and the potential for societal division.

THE DREAM OF CONNECTING MINDS

The concept of linking the human brain to computers, once confined to science fiction, is rapidly becoming a reality. This endeavor, known as brain-computer interfaces (BCIs), holds immense potential for aiding individuals with disabilities by bypassing damaged nerves, restoring lost senses, and possibly offering enhancements. The journey began with early discoveries of brain electrical activity, leading to rudimentary yet functional BCIs like cochlear implants and EEG headsets.

NEURALINK'S AMBITIOUS VISION AND CHALLENGES

Elon Musk's Neuralink emerged with a vision to create a next-generation BCI, the 'Link,' featuring 1,008 electrodes thinner than a human hair, implanted by a robotic system. This bidirectional device aims not only to read but also to write brain signals, potentially restoring sight or enabling thought-controlled communication. However, Neuralink has faced significant hurdles, including electrode retraction issues in human trials, FDA citations for animal testing facilities, and internal disagreements, leading to a co-founder's departure.

PRECISION NEUROSCIENCE: A SAFER, MORE HUMAN-CENTRIC APPROACH

Co-founded by ex-Neuralink member Ben Rapaort, Precision Neuroscience offers a contrasting approach. Their 'Layer 7 Cortical Interface' is an ultra-thin, flexible array that sits on the brain's surface without damage or scarring. Focused solely on medical applications and patient well-being, Precision has conducted multiple human implants, emphasizing safety and the ability to temporarily implant and easily remove the device, differentiating itself from Neuralink's enhancement-driven goals.

SYNCHRON'S ENDOVASCULAR INNOVATION

Synchron presents a distinct, less invasive method by delivering its BCI, the 'Stentrode,' through blood vessels. This approach avoids brain surgery altogether, utilizing existing stroke treatment procedures. While it may offer lower signal resolution compared to direct brain contact, it is sufficient for basic functions like cursor control and texting, representing the safest entry point into the BCI field with FDA approval for longer-term trials.

BLACKROCK NEUROTECH AND RESTORING SPEECH VIA AI

Blackrock Neurotech, an established BCI company, has achieved a significant breakthrough with its 'Move Again' system. This technology enabled a paralyzed ALS patient to speak again by reading his brain signals and using AI to decode them into audible speech in real-time, mirroring his own voice. The system demonstrated remarkable accuracy, surpassing many voice recognition applications and offering a profound restoration of communication.

ETHICAL DILEMMAS AND THE FUTURE OF BCIS

The burgeoning field of BCIs elicits profound ethical debates. While the therapeutic applications for treating debilitating conditions are widely accepted, the potential for non-medical enhancement and augmentation raises concerns about societal division, human identity, and consciousness. Legal questions surrounding brain data ownership, storage, and the risks of hacking also loom large, emphasizing the need for careful consideration as this technology advances.

Mentioned in This Episode

●Products

●Software & Apps

●Companies

●People Referenced

Common Questions

A brain-computer interface (BCI) is a technology that allows users to control computers or other devices using only their brain activity. Functional BCIs have existed for about 30 years, with early versions like EEG headsets measuring brain waves.

Topics

Precision Neuroscience Synchron Blackrock Neurotech Human Enhancement

Mentioned in this video

personMichael Mega

CEO and co-founder of Precision Neuroscience, emphasizing patient care and safety over AI symbiosis.

productThe Link

Neuralink's brain implant device, featuring 1024 electrodes across 64 threads that penetrate brain tissue.

companyPrecision Neuroscience

A rival company co-founded by a former Neuralink co-founder, focusing on less invasive BCI technology deployed on the surface of the brain.

productLayer 7 cortical interface

Precision Neuroscience's BCI device featuring 1024 electrodes on a thin, flexible film that conforms to the brain's surface without implantation into tissue.

productMove Again system

Blackrock Neurotech's BCI system that uses silicon microelectrodes to enable speech in paralyzed individuals via AI decoding.

personNoland Arbaugh

The first human patient to receive a Neuralink implant, a quadriplegic man who used the device to control a computer cursor with his thoughts.

personBen Rapoport

A co-founder of Neuralink who later left due to disagreements over invasiveness and founded Precision Neuroscience.

personDavid Brandman

Neurosurgeon and co-leader of the Blackrock Neurotech speech BCI study, highlighting its high accuracy.

companyBlackrock Neurotech

An experienced BCI company known for its 'Move Again' system, which has enabled paralyzed individuals to speak.

productR1

toolstent